The assessment of opioid withdrawal in the neonate, or neonatal opioid withdrawal syndrome (NOWS), is problematic because current assessment methods are based on subjective observer ratings. Crying is a distinctive component of NOWS assessment tools and can be measured objectively using acoustic analysis.
PedialyDx has received a notice of award for our phase 2 SBIR titled 'Diagnosis of Neonatal Opioid Withdrawal Syndrome (NOWS) and Development of a NOWS-App', which will support a 7-site study to increase our NOWS data and support development of NOWS-App product.
Get in touch with us to learn more about the work we are doing, inquire about upcoming studies, or discuss potential investment opportunities.
